Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane Freeman

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
The Journal of Antimicrobial Chemotherapy|October 1, 2005
Surveillance for resistance to metronidazole and vancomycin in genotypically distinct and UK epidemic Clostridium difficile isolates in a large teaching hospitalJane Freeman, Joanna Stott, Simon D Baines, et al.
The Journal of Antimicrobial Chemotherapy|September 24, 2016
Role of cephalosporins in the era of Clostridium difficile infectionMark H Wilcox, James D Chalmers, Carl E Nord, et al.
Heart, Lung & Circulation|September 28, 2010
Anaemia in heart failure: a prospective evaluation of clinical outcome in a community populationTanya Stewart, Jane Freeman, Jessica Stewart, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 29, 2023
Hear my voice: involving patients in Clostridioides difficile infection researchJudith Strawbridge, John Heritage, Marcela Krůtová, et al.
The Journal of Antimicrobial Chemotherapy|February 13, 2009
Mecillinam: a low-risk antimicrobial agent for induction of Clostridium difficile infection in an in vitro human gut modelSimon D Baines, Rachael O'Connor, Grace Huscroft, et al.
The Journal of Antimicrobial Chemotherapy|March 12, 2011
Nitazoxanide is active against Clostridium difficile strains with reduced susceptibility to metronidazoleJane Freeman, Simon D Baines, Sharie L Todhunter, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 21, 2025
Current challenges in real-world management of Clostridioides difficile infectionGuido Granata, Kerrie Davies, Benoit Guery, et al.
The Journal of Antimicrobial Chemotherapy|May 28, 2004
Long-term surveillance of cefotaxime and piperacillin-tazobactam prescribing and incidence of Clostridium difficile diarrhoeaMark H Wilcox, Jane Freeman, Warren Fawley, et al.
The Journal of Antimicrobial Chemotherapy|June 23, 2023
In vivo emergence of a still uncommon resistance to fidaxomicin in the urgent antimicrobial resistance threat Clostridioides difficileHélène Marchandin, Cyril Anjou, Gaëtan Poulen, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 2015
Recurrence of dual-strain Clostridium difficile infection in an in vitro human gut modelGrace S Crowther, Caroline H Chilton, Sharie L Todhunter, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
The Journal of Antimicrobial Chemotherapy|October 1, 2005
Surveillance for resistance to metronidazole and vancomycin in genotypically distinct and UK epidemic Clostridium difficile isolates in a large teaching hospitalJane Freeman, Joanna Stott, Simon D Baines, et al.
The Journal of Antimicrobial Chemotherapy|September 24, 2016
Role of cephalosporins in the era of Clostridium difficile infectionMark H Wilcox, James D Chalmers, Carl E Nord, et al.
Heart, Lung & Circulation|September 28, 2010
Anaemia in heart failure: a prospective evaluation of clinical outcome in a community populationTanya Stewart, Jane Freeman, Jessica Stewart, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 29, 2023
Hear my voice: involving patients in Clostridioides difficile infection researchJudith Strawbridge, John Heritage, Marcela Krůtová, et al.
The Journal of Antimicrobial Chemotherapy|February 13, 2009
Mecillinam: a low-risk antimicrobial agent for induction of Clostridium difficile infection in an in vitro human gut modelSimon D Baines, Rachael O'Connor, Grace Huscroft, et al.
The Journal of Antimicrobial Chemotherapy|March 12, 2011
Nitazoxanide is active against Clostridium difficile strains with reduced susceptibility to metronidazoleJane Freeman, Simon D Baines, Sharie L Todhunter, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 21, 2025
Current challenges in real-world management of Clostridioides difficile infectionGuido Granata, Kerrie Davies, Benoit Guery, et al.
The Journal of Antimicrobial Chemotherapy|May 28, 2004
Long-term surveillance of cefotaxime and piperacillin-tazobactam prescribing and incidence of Clostridium difficile diarrhoeaMark H Wilcox, Jane Freeman, Warren Fawley, et al.
The Journal of Antimicrobial Chemotherapy|June 23, 2023
In vivo emergence of a still uncommon resistance to fidaxomicin in the urgent antimicrobial resistance threat Clostridioides difficileHélène Marchandin, Cyril Anjou, Gaëtan Poulen, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 2015
Recurrence of dual-strain Clostridium difficile infection in an in vitro human gut modelGrace S Crowther, Caroline H Chilton, Sharie L Todhunter, et al.
Pageof 6